- Our Doctors
- Dr Christos Mikropoulos
/content/dam/genesiscare/headshots/uk-doctor-headshots/UK_Oncology_Head_shot_GA_Christos_Mikropoulos.jpg
Dr Christos Mikropoulos
Dr Christos Mikropoulos
Christos
Mikropoulos
MBBS, MSc, MD (Res), MRCP, FRCR, Clinical oncologist
Languages spoken
English
Expert in
Gastrointestinal cancer, genitourinary cancer, urological cancers
Overview
Centres
Guildford
Guildford
BMI St Martha Oncology Centre, 46 Harvey Road, Guildford, Surrey, GU1 3LX, England, UK
51.235397, -0.563871
/uk/our-centres/guildford
Surrey
Specialises in
Bladder cancer
Colorectal cancer
Gynaecological cancer
Treatments
Christos Mikropoulos is a Consultant Clinical Oncologist specialising in the treatment of colorectal and urological cancers including prostate, bladder, and testicular. He is trained in advanced techniques for radiotherapy including MR Linac, SABR and Brachytherapy. His research interests include cancer genetics and bio markers. Currently a Clinical Oncology Consultant at the Royal Surrey (St Luke's Unit) where he also treats Haematological Malignancies with Radiotherapy and Stereotactic Radiotherapy for Oligometastatic Disease.
- Trained in Clinical Oncology at the Royal Marsden, Guy's and St Thomas's and Kent Oncology Centre.
- Completed MRCP in 2008
- Merit MSc in Oncology in 2007
- Completed FRCR in 2013
- Completed MD (research) in Cancer Genetics at the ICR in 2015
Career positions
Current position(s)
- Clinical oncologist, Royal Surrey County Hospital
Education
Universities
- Master of Science, Newcastle University, Newcastle
- MD (Research), University of London, Institute of Cancer Research (ICR)
Expertise and interests
Interests
- Prostate cancer; Bladder cancer; Testicular Cancer; Prostate Brachytherapy; Colorectal Cancer; MR Linac; Stereotactic Radiotherapy
Professional associations
- Member of the Royal College of Physicians (MRCP)
- Fellow of the Royal College of Radiologists (FRCP)
- Member of the European Society of Medical Oncology (ESMO)
- Member of the European Society of Therapeutic Radiation Oncology (ESTRO)
Accomplishments
Awards recieved
- Merit Award GU ASCO 2014 for Poster Presentation on ‘PROFILE: Results of a pilot study on targeted prostate cancer screen for men with family history of prostate cancer’.
- 2014 Ross RCR Poster Award for ‘The prevalence of the HOXB13 mutation in UK men and correlation with phenotype and outcomes’.
- Merit Award GU ASCO 2015 for the Poster Presentation on ‘The IMPACT study: Identification of Men with a genetic predisposition to ProstAte Cancer: Targeted screening in men at higher genetic risk and controls: Prostate-Specific Antigen Velocity as a predictive biomarker in a prospective Prostate Cancer Screening Study of Men with genetic predisposition.’
Publications
- Co-investigator and developer of the GENPROS study, which is a non-interventional study that will collect clinical outcome data for men diagnosed with prostate cancer with a known germline genetic predisposition.
- Co-investigator and developer of the GENPET study, which is an imaging single arm study assessing the sensitivity of F-Choline-PET to detect nodal metastases in men with a germline BRCA mutation.
- Co-investigator and developer of the BARCODE-1 study – a prostate cancer screening study which will genetically profile 5000 men and identify the top 10% men at most genetic risk and offer them a diagnostic prostatic biopsy.